Centrica PLC Transaction in Own Shares (3860L)
30 Décembre 2022 - 02:30PM
UK Regulatory
TIDMCNA
RNS Number : 3860L
Centrica PLC
30 December 2022
Transactions in own shares
Centrica plc
30 December 2022
Centrica plc announces that today it purchased (through UBS AG
London Branch) 502,640 Centrica plc ordinary shares of 6 (14) /(81)
pence each at a price of 96.5117 pence per share. The purchased
shares will be held as treasury shares. Such purchase was effected
pursuant to the Company's buyback programme (details of which were
as announced on 15 November 2022) and effected in accordance with
the non-discretionary share repurchase agreement entered into with
UBS AG London Branch, as announced on 15 November 2022.
Since 15 November 2022, Centrica has purchased 47,201,133
ordinary shares at a cost (excluding dealing and associated costs)
of GBP44,246,753.46.
Following the above purchase, Centrica plc holds 47,171,692
ordinary shares in treasury, and has 5,860,674,446 ordinary shares
in issue (excluding treasury shares).
In accordance with Article 5(1)(b) of Regulation (EU) No
596/2014 (the Market Abuse Regulation) (as in force in the UK and
as amended by the Market Abuse (Amendment) (EU Exit) Regulations
2019), detailed information about the individual purchases made by
UBS AG London Branch is set out below.
Transaction details: Centrica plc ordinary shares of 6 (14)
/(81) pence each
Issuer name: Centrica plc
ISIN: GB00B033F229
Intermediary name: UBS AG London Branch
Intermediary Code: UBSWGB2L
Currency: GBP
Aggregated information
Date of purchase: 30 December 2022
Number of ordinary shares purchased: 502,640
-----------------
Highest price paid 96.86p
-----------------
Lowest price paid 96.12p
-----------------
Volume weighted average price paid
per share (p): 96.5117p
-----------------
Disaggregated information
The table attached contains detailed information of the
individual trades made by UBS AG London Branch, as part of the
buyback programme.
Click on, or paste the following link into your web browser, to
view the associated PDF document.
http://www.rns-pdf.londonstockexchange.com/rns/3860L_1-2022-12-30.pdf
END
Enquiries:
Investors and Analysts
T: 01753 494900
E: ir@centrica.com
Centrica plc is listed on the London Stock Exchange (CNA)
Registered Office: Millstream, Maidenhead Road, Windsor,
Berkshire SL4 5GD
Registered in England & Wales number: 3033654
Legal Entity Identifier number: E26EDV109X6EEPBKVH76
ISIN number: GB00B033F229
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
POSGZMFZFGNGZZM
(END) Dow Jones Newswires
December 30, 2022 08:30 ET (13:30 GMT)
Centrica (LSE:CNA)
Graphique Historique de l'Action
De Fév 2024 à Mar 2024
Centrica (LSE:CNA)
Graphique Historique de l'Action
De Mar 2023 à Mar 2024